Inclusion of genetic variants in an ensemble of gradient boosting decision trees does not improve the prediction of citalopram treatment response
Abstract Identifying in advance who is unlikely to respond to a specific antidepressant treatment is crucial to precision medicine efforts. The current work leverages genome-wide genetic variation and machine learning to predict response to the antidepressant citalopram using data from the Sequenced...
Guardado en:
Autores principales: | Jason Shumake, Travis T. Mallard, John E. McGeary, Christopher G. Beevers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e984ede38424cfeb69f6eeec4c072b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bagging-gradient boosting decision tree based milling cutter wear status prediction modelling
por: Weiping Xu, et al.
Publicado: (2021) -
iEnhancer-MFGBDT: Identifying enhancers and their strength by fusing multiple features and gradient boosting decision tree
por: Yunyun Liang, et al.
Publicado: (2021) -
Forecasting of Carbon Emission in China Based on Gradient Boosting Decision Tree Optimized by Modified Whale Optimization Algorithm
por: Xiwen Cui, et al.
Publicado: (2021) -
Application of gradient tree boosting regressor for the prediction of scour depth around bridge piers
por: B. M. Sreedhara, et al.
Publicado: (2021) -
Artificial Flora Algorithm-Based Feature Selection with Gradient Boosted Tree Model for Diabetes Classification
por: P N, et al.
Publicado: (2021)